- Home
- AXSM vs BIPC Comparison
AXSM vs BIPC Comparison
Compare AXSM & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- BIPC
- Stock Information
- Founded
- AXSM 2012
- BIPC 2019
- Country
- AXSM United States
- BIPC United States
- Employees
- AXSM N/A
- BIPC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- BIPC Marine Transportation
- Sector
- AXSM Health Care
- BIPC Consumer Discretionary
- Exchange
- AXSM Nasdaq
- BIPC Nasdaq
- Market Cap
- AXSM 5.1B
- BIPC 4.7B
- IPO Year
- AXSM 2015
- BIPC N/A
- Fundamental
- Price
- AXSM $100.69
- BIPC $40.77
- Analyst Decision
- AXSM Strong Buy
- BIPC
- Analyst Count
- AXSM 16
- BIPC 0
- Target Price
- AXSM $170.50
- BIPC N/A
- AVG Volume (30 Days)
- AXSM 627.1K
- BIPC 684.8K
- Earning Date
- AXSM 08-04-2025
- BIPC 01-01-0001
- Dividend Yield
- AXSM N/A
- BIPC 4.25%
- EPS Growth
- AXSM N/A
- BIPC N/A
- EPS
- AXSM N/A
- BIPC N/A
- Revenue
- AXSM $432,157,000.00
- BIPC $3,693,000,000.00
- Revenue This Year
- AXSM $62.84
- BIPC $8.95
- Revenue Next Year
- AXSM $60.02
- BIPC $6.21
- P/E Ratio
- AXSM N/A
- BIPC N/A
- Revenue Growth
- AXSM 72.16
- BIPC 26.99
- 52 Week Low
- AXSM $72.02
- BIPC $32.08
- 52 Week High
- AXSM $139.13
- BIPC $43.26
- Technical
- Relative Strength Index (RSI)
- AXSM 37.30
- BIPC 56.62
- Support Level
- AXSM $99.39
- BIPC $41.01
- Resistance Level
- AXSM $112.98
- BIPC $41.99
- Average True Range (ATR)
- AXSM 3.33
- BIPC 0.75
- MACD
- AXSM -0.76
- BIPC -0.12
- Stochastic Oscillator
- AXSM 9.35
- BIPC 58.50
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.